Article

The latest myeloma treatment advances from ASCO 2023

The 2023 American Society of Clinical Oncology (ASCO) annual meeting was held from June 2 to 6 in Chicago! Clinicians and researchers gathered to present and discuss several updates in multiple myeloma relating to: Chimeric antigen receptor (CAR) T-cell therapies, Bispecific antibodies (also known as T-cell engagers) in combination or as monotherapy, Treatment for newly diagnosed disease, and Maintenance therapy. Let us break down the key findings for you…

Link: https://themmrf.org/2023/06/08/the-latest-myeloma-treatment-advances-from-asco-2023/

Related Videos
Kristie L. Kahl and Mary Derome
Kristie L. Kahl and Amy Pierre
Kristie L. Kahl and Dr. Nina Shah
Kristie L. Kahl and Dr. Hearn J. Cho
Kristie L. Kahl and Dr. Irene Ghobrial
Related Content
Site Logo
June 21st 2023

Myeloma Investment Fund Invests in Nectin Therapeutics to Evaluate Nectin’s Anti-PVR Lead Drug Candidate as a Treatment for Multiple Myeloma

Site Logo
March 5th 2020

Laugh for Life

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with the co-chair of the MMRF’s Laugh for Life event, as well as this year’s “Spirit of Hope” award recipient.
Site Logo
June 21st 2023

The MIF Invests in Luminary Therapeutics, KAHR, and Telo Therapeutics to Accelerate Novel Therapies for the Treatment of Multiple Myeloma

Site Logo
June 21st 2023

MMRF Programs Drive Advances in Cancer Research at 64th American Society of Hematology (ASH) Annual Meeting

Site Logo
June 21st 2023

MMRF Statement on FDA Approval of TECVAYLI™, the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

How a Hike on Mount Everest to Raise Awareness, Funds for Blood Cancer Forever Changed the Lives of the Participants
October 10th 2022

How a Hike on Mount Everest to Raise Awareness, Funds for Blood Cancer Forever Changed the Lives of the Participants

Ryan McDonald
In 2018, 18 trekkers completed an awe-inspiring hike of the Himalayan highlands to the doorstep of the world’s tallest mountain, Mount Everest, to raise awareness and funding for multiple myeloma, a type of blood cancer. Three of the climbers discuss a bond that hasn’t broken.